Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 147.50
-1.50 (-1.01%)
Oct 9, 2025, 1:30 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 12.50 billion as of October 10, 2025. Its market cap has decreased by -37.89% in one year.
Market Cap
12.50B
Enterprise Value
12.12B
Revenue
4.26B
Ranking
n/a
PE Ratio
14.13
Stock Price
147.50
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 12.50B, an increase of 1,142.95%. That is a compound annual growth rate of 16.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 12.50B | -26.25% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | 18.19B | 254.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |